Aptadel Therapeutics

This biotech company develops RNA Aptamer-based therapeutics for cancer treatment, utilizing a platform that links Aptamers to small RNA molecules and chemotherapeutic agents. By targeting specific tumors, the technology aims to enhance treatment efficacy while minimizing side effects for patients.

Traction 7/10

Barcelona, Spain · HQ

Founded 202071K+ followers

Biotechnology

Updated 23 months ago

Funding

Raised to date

$2.1MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

4 founders

Gisela Lorente

CEO

Nadia Pons

COO

Oscar Martinez Tirado

Head of the Sarcoma Research Group

Paloma Giangrande

Biotech Executive

Product

Features

This biotech company develops RNA Aptamer-based therapeutics for cancer treatment, utilizing a platform that links Aptamers to small RNA molecules and chemotherapeutic agents. By targeting specific tumors, the technology aims to enhance treatment efficacy while minimizing side effects for patients.